Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totaling 328 shares, a growth of 150.4% from the April 15th total of 131 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 713 shares, the short-interest ratio is currently 0.5 days.
Mosaic ImmunoEngineering Stock Performance
OTCMKTS:CPMV remained flat at $0.69 during trading hours on Friday. 1 shares of the company’s stock were exchanged, compared to its average volume of 398. The stock has a fifty day moving average of $0.65 and a 200-day moving average of $0.58. The firm has a market cap of $5.03 million, a price-to-earnings ratio of -6.95 and a beta of -0.68. Mosaic ImmunoEngineering has a 52 week low of $0.25 and a 52 week high of $1.05.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last posted its quarterly earnings data on Wednesday, April 15th. The company reported ($0.03) earnings per share for the quarter.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.
Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.
Read More
- Five stocks we like better than Mosaic ImmunoEngineering
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
